MedTrace Logo

Evaluation of Mosquito Repellent Products' Efficacy, Safety, and Public Health Implications

NCT07686159 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2026-07-07

No results posted yet for this study

Summary

Human Volunteer Participation:

A total of six (6) healthy adult volunteers participated in the study, including three males and three females aged between 18 and 22 years. The volunteers participated in:

* Arm-in-Cage Test Procedure
* Dermatological Safety Test

All participants were:

* Non-tobacco users
* Free from dermatosis or chronic skin disease
* Free from known allergic reactions to arthropod bites or mosquito repellents
* Informed regarding the objectives, procedures, risks, and benefits of the study Written informed consent was obtained from all volunteers before participation. Participants were instructed not to apply perfumes, aromatics, skincare products, or other mosquito repellents on the hands for at least 12 hours before and during the experiment to minimize experimental bias.

Safety and Ethical Considerations:

1. All experiments were conducted under controlled laboratory conditions.
2. Appropriate safety precautions and monitoring procedures were maintained throughout the study.
3. Volunteers retained the right to withdraw from the study at any stage without penalty.
4. Confidentiality and anonymity of volunteer information were strictly maintained.
5. No severe physical or psychological risk was associated with participation.
6. Immediate medical support and first-aid facilities were available during experimentation.

Conditions

  • Mosquito Repellent
  • Mosquito Bite

Interventions

DEVICE

Mosquito Repellent Products (Topical and Spatial Formulations)

Specialized rubber gloves designed to expose only a 4 × 4 cm area of dorsal hand skin while protecting the rest of the hand. Gloves were replaced between trials to prevent cross-contamination or residual repellent effects.

Sponsors & Collaborators

  • Texas A&M University

    collaborator OTHER

  • University of Washington

    collaborator OTHER

  • Swiss Tropical and Public Health Institute (Switzerland)

    collaborator UNKNOWN

  • Chinese Academy of Sciences

    collaborator OTHER_GOV

  • Tsinghua University

    collaborator OTHER

  • University of Basel

    collaborator OTHER

  • Military Institute of science and Technology

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-25
Primary Completion
2025-10-25
Completion
2025-11-05

Countries

  • Bangladesh

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07686159 on ClinicalTrials.gov